Cubist Systematic Strategies, LLC Paratek Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $67,793 - $121,087	-39,187 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $78,383 - $127,172	26,661 Added 212.85%	39,187 $116,000
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $50,980 - $66,387	12,526 New	12,526 $56,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $171,484 - $264,158	-36,486 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $45,947 - $73,744	6,747 Added 22.69%	36,486 $249,000
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $54,412 - $73,643	-8,862 Reduced 22.96%	29,739 $210,000
Q4 2020 Feb 16, 2021	SELL	$4.58 - $7.14 $74,864 - $116,710	-16,346 Reduced 29.75%	38,601 $242,000
Q3 2020 Nov 16, 2020	BUY	$4.19 - $6.69 $230,227 - $367,595	54,947 New	54,947 $297,000
Q2 2019 Aug 14, 2019	SELL	$3.47 - $6.32 $89,966 - $163,858	-25,927 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.36 - $7.24 $11,036 - $14,907	2,059 Added 8.63%	25,927 $139,000
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $114,566 - $276,868	23,868 New	23,868 $122,000
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $114,994 - $156,708	-11,274 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $142,616 - $212,514	11,274 New	11,274 $147,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.